Remove Aging and mental health Remove Bipolar disorder Remove Eating disorders
article thumbnail

FDA Requires New Label Warning of Weight Loss Risk in Pediatric Patients Taking Extended-Release Stimulants for ADHD

Psychiatric Times

SHOW MORE The FDA will update ADHD medication labels, warning of weight loss risks in children under 6, urging careful monitoring by health care professionals. Healthcare professionals should monitor weight and growth in young patients on these medications and consider alternative treatments if adverse effects occur.

article thumbnail

ADHD Treatment Options

Psychiatric Times

Overview of Attention Deficit/Hyperactivity Disorder EP: 2. ADHD in Elementary School Age Child: Patient Case 1 EP: 3. ADHD Diagnosis Criteria EP: 4. Challenges in Diagnosing ADHD EP: 5. Impact of ADHD on Patient’s Quality of Life EP: 6. Risk Factors for ADHD EP: 7.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Do Psychiatry Residents Learn Psychopharmacology?

Psychiatric Times

Follow the age-old axiom of “say what you’re going to say, say it, and then say what you said.” Do it slightly differently each time, and preferably with increasing levels of associative limbic cues (humor?

Education 123
article thumbnail

Nonstimulant Therapies for ADHD

Psychiatric Times

Overview of Attention Deficit/Hyperactivity Disorder EP: 2. ADHD in Elementary School Age Child: Patient Case 1 EP: 3. ADHD Diagnosis Criteria EP: 4. Challenges in Diagnosing ADHD EP: 5. Impact of ADHD on Patient’s Quality of Life EP: 6. Risk Factors for ADHD EP: 7.

article thumbnail

Risk Factors for ADHD

Psychiatric Times

Overview of Attention Deficit/Hyperactivity Disorder EP: 2. ADHD in Elementary School Age Child: Patient Case 1 EP: 3. Related Videos Related Content Advertisement June 17th 2025 ADHD With Bipolar Disorder: Genetics, Diagnosis, and New Thinking on Treatment David N. ADHD Diagnosis Criteria EP: 4. Subscribe Now!

article thumbnail

History, Physiology, and Pharmacology of Incretins

Psychiatric Times

FDA Indications, Potential Future Indications, and Areas of Investigation for GLP-1 RAs Soon after their introduction, GLP-1 RAs’ significant weight-lowering effects and health benefits in other medical disorders became apparent, with relatively greater metabolic and weight loss benefits reported with newer GLP-1 RAs and dual agonists.

59
article thumbnail

Intergenerational Gaps and the Role of Technology in Psychiatric Leadership: A Trainee’s Perspective

Psychiatric Times

As the newest cohort in psychiatric training, they are digital natives, accustomed to rapid information retrieval, online simulations, and mental health apps. 9 Another major technological shift in medicine has been the integration of electronic health records (EHRs). 4 Why Is Technology at the Center of the Conversation?